HC Wainwright Forecasts Strong Price Appreciation for Nuvation Bio (NYSE:NUVB) Stock
Nuvation Bio (NYSE:NUVB – Free Report) had its price objective upped by HC Wainwright from $10.00 to $11.00 in a research ...
What is HC Wainwright’s Forecast for MNPR FY2026 Earnings?
Research analysts at HC Wainwright upped their FY2026 earnings estimates for Monopar Therapeutics in a report issued on Wednesday, January 22nd. HC Wainwright analyst S. Lee now expects that the ...
H.C. Wainwright cuts ALX Oncology target to $5, keeps buy rating
H.C. Wainwright analysts have reduced the price target for ALX Oncology (NASDAQ:ALXO) shares to $5 from the previous $25 ...
Lexaria Bioscience stock target cut to $7 at H.C. Wainwright
H.C. Wainwright adjusted its price target for Lexaria Bioscience (NASDAQ:LEXX) to $7.00, down from the previous target of $10.00, while maintaining a Buy rating on the company's shares. With the stock ...
LSI Industries price target raised to $30 from $20 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on LSI Industries (LYTS) to $30 from $20 and keeps a Buy rating on the shares. The firm cites ...
Lexaria Bioscience price target lowered to $7 from $10 at H.C. Wainwright
H.C. Wainwright analyst Yi Chen lowered the firm’s price target on Lexaria Bioscience (LEXX) to $7 from $10 and keeps a Buy rating on the ...
Seeking Alpha24d
Corvus wins new buy from H.C. Wainwright despite recent selloff
H.C. Wainwright launched its coverage of eczema drug developer Corvus Pharmaceuticals (NASDAQ:CRVS) with a Buy recommendation and an $11 per share target on Thursday, despite an over 38% drop ...
Nasdaq18d
H.C. Wainwright ups Sana target after ‘best case scenario’ data
H.C. Wainwright raised the firm’s price target on Sana Biotechnology (SANA) to $11 from $8 and keeps a Buy rating on the shares. The firm increased its probability of sucess for SC451 to 15% ...
Nasdaq27d
MetaVia initiated with a Buy at H.C. Wainwright
H.C. Wainwright initiated coverage of MetaVia (MTVA) with a Buy rating and $12 price target The company’s DA-1726 is a novel oxyntomodulin analogue designed as a dual agonist targeting glucagon ...
bovnews4d
Why Did H.C. Wainwright Give Immunic Inc (IMUX) Stock Buy Rating?
Immunic Inc (IMUX) stock saw a modest uptick, ending the day at $0.95 which represents no change from the prior close of of $0.95. The stock opened at $0.98 and touched a low of $0.92 during the day, ...
cryptopolitan5d
BTCS Inc. to Participate in Fireside Chat with Blockdaemon hosted by H.C. Wainwright
BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a leader in blockchain infrastructure and technology, has announced its ...
Yahoo Finance1mon
Palvella Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright initiated coverage of Palvella Therapeutics (PVLA) with a Buy rating and $38 price target Palvella’s lead product, QTORIN 3.9% rapamycin anhydrous gel, is currently in ...